Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am now captain $270K, 10 percent of European revenue which has had 6 years of effort.
Europe may not sustain 35 percent growth either, we shall see. Last 5 quarters have ranged from $580K to around $700K
So worst management ever has a chance (after Hobbs 2009 to 2013 seen almost as bad) to get approval. Not the way I would think
Nor at this point do I think it is commendable for those who would love to completely destroy this company.
I think Simpson has not only crafted a good chance at approval, but also between the 2 trials the best chance to make this product commercially attractive. A far harder task than most bears and longs understand.
The vote will maybe supply fuel to thinking, so far I stand alone
Sometimes you are almost optimistic, more so than some regarding this company. Yes or no?
My position is strange. It is also strange holding or buying if one thinks reverse split will cause price to go down.
I will reiterate Simpson appears to be doing the correct actions ever since the first NO vote in June. She was right to override the two NO votes, although YES outnumbered NO.
I don't expect a company to just declare itself a bad investment, shut down operations, and issue one time dividend off cash at hand.
If that was a good idea it should have been done maybe as early as 2010 or 2011, take your pick.
Any stumble for delcath whether the fault of management, etc.. could mean losing money.
Delcath may not even qualify as a good company if it reaches $1 billion market cap. If the company has an upward trend of very high revenue year after year, then maybe just a plain old good company
What would be the point of discrediting. It is rational to fear bad companies. It does not matter the manner of bad, bad is bad.
I can fear delcath, but still find attractive qualities.
Fear, hatred, and anger towards the company are all real.
My belief is new people are persuaded more by buy sentiment than avoid/sell sentiment. Right now, it is status quo, not much buying or selling
That is just it, if it is irritants deserving of SEC action okay, sort of. But if the irritant in my judgement is just too small, you are not doing investors a service but a detriment. I am on the sidelines currently, but I would not be happy to see my money impacted in a negative fashion if the redeeming features are not so much.
Freeing up the product is just a theory, theory, theory so maybe you should be the apologist
Some people love the idea of lawyers and courts, not that it would likely give them significant payback if any for financial loss.
As well it is an imperfect world, dreaming of righting wrongs, so simplistic. Just the potential to add to chaos instead of setting the world ever so straight
The past offering is strange to us all. If I was in the offering, I might see 1 cent / $5 as the dividing line between sell and hold. I also think Simpson is raving mad to hold a vote if this offering bunch is not on board. All guesses on my part.
Unless Simpson is playing a deceptive game to just get the authorized approved as backup and seeing if the crowd responds big to a NO vote. An interesting play on a split vote
I expect 212 million from that quarter. That makes YES highly likely. The 212 million don't need to short according to 35 percent of volume up to 212 million being available above one cent I should think
This board is locked up tight. 95 percent probably voted NO on reverse split. Maybe an injunction? Lots of getting in touch with SEC over last few months. Lots of people rooting for lawsuits.
What more could you ask for? Plenty of posts about thievery/fraud. You have gotten everything, but what more but to see who wins
Simpson vs. little retail
The technology is good, but it may not be valuable. Whether it is valuable or not, I don't think b/o is near term.
There can't be another convertible for this company to be worthy of investor consideration.
What about chief finance officer? I was aware of some of the bod background. At the heart of the matter I believe Simpson when she indicates a lack of b/o or partner interest
I think the right way to look is forward. If there is an offering ahead, what price and what amount raised? that is all a big deal
Keep in mind Stoll then has always had knowledge with the industry during his years with delcath. On his watch, nothing fruitful.
The other thing is nobody is putting up b/o numbers which has been a hot topic in the past. Share count a little iffy obviously. Simpson always said the interest is not there, I believe her
To continue the thought it is not the BOD usually that is the way to distinguish.
It is the individual company and head being Simpson. Too bad you don't see the convertible all alone that stands out as the reason nobody really likes the company.
Otherwise Delcath has gotten much better looking than Sep 2013 which had the higher market cap. People did not know how difficult and long the path, the lack of b/o interest, the total flop on European revenue. The revenue was already suspect by then, but now 6 years of flop
Roger Stoll has been on board with delcath many years. Some therefore don't think well of Stoll.
I can't see that Delcath operates differently since addition of Pedder
CHARLOTTE DIVISION·DOCKET NO. 3:12-cv-00213-MOC-DCK (W.D.N.C. Aug. 26, 2015)
Zak v. Simon Pedder L. Arthur Hewitt J. Nick Riehle Chelsea Therapeutics Int'l, Ltd.
Jul 10, 2012 - Chelsea Therapeutics is cutting employees and has revamped its management, with company founder Simon Pedder resigning as president and chief executive. (he was a defendant in a lawsuit over than as well
Assuming reverse split, I would like to see an offering done for at least $8 million. This is where the focus should be.
If not reverse split, but 500 million shares if authorized approved, I still look for an offering
I honestly don't care about any of that, my due diligence is solely focused on other aspects of the company. If you turned up that European revenue was not real or clinical trials was not real or offerings were not real ... Also this is I am assuming, a correctly audited company, so you would have to ask questions about auditor etc..
My opinion YES released, and I have always thought the patents were at all times a non issue
I am the only one that thought Simpson did a superb job of laying out phase 3 status. It is not a guarantee of anything. My 2nd point would be regardless of quality of filings, they are a better source of information than message boards. For real estate I don't know, but for phase 3 and votes and offerings, I know what source to focus on
If it is for sale, likely so. That would be normal. The gist of what I noted before was there were failed attempts to reach anybody in the office.
I don't read the latest filings on real estate. This is not helping to focus imo on the biggies of the vote, implications of YES or NO, etc..
Why not focus instead then on that 10K states according to rap's post that 7 new employees were added due to clinical trials and European effort?
Right now I am happy I sold before reverse split. If the 4th reverse split, I held through the first 2 and sold before the last 2.
I can't explain but how would you explain 8000 feet if empty. The company would not throw away money for no reason. Reason? Something?
I don't even know the actual facts. Did somebody actually walk around and look in the offices first hand
Sublease was to save money, right? To lawyers, more likely than janitors for expensive space. Working relationship, maybe, they need lawyers for a public company
If there are calls to be made, first calls would be if needed to Roth's Indians according to my long standing theory. Probably a Roth representative or Simpson herself would place those calls
Let us say company has spent $300 million so far where it should have been $150 million. The primary problem people has is the convertible, it is not reverse splits, it is the convertible. It is not too much on salaries or NYC location, these could be seen as irritants.
Everybody has a laundry list of dislikes, but clinically I claim Simpson is one sharp cookie.
Yes, enny menny miny moe will the REAL capt. 370 stand up
The future is 100 percent about Simpson until there is REAL proof of otherwise. Shareholders as well have to prove they have a real plan to circumvent Simpson. It would take big Indians to do that like Roth Indians aka the silent bunch IF they were so inclined
The only thing worse than regurgitating posts almost a year back is to slant the actual quote. The current SAM message is don't believe in Buffalo, that is my tip for the track
The company would be lucky imo to get $270K annual from such a bill. Capt 370 must have jumped from my heart to yours
If delcath gets millions of more dollars through financings, then maybe on the clinical front there will be positive news a few months down the line for enrollment
The company can't change anything without money. A company like this is a crapshoot, probably been around since at least 1999. So years and years of money goes in. Hundreds of millions of dollars no doubt burned. A terrible enterprise, that is the way to see.
But no doubt there have been some people as longs that pocketed hundreds of thousands of dollars and walked away. Some of those people may come back and catch a little wave again, no telling
Yes, the care is proven by voting NO. I would like to see Simpson snatch a little victory from the jaws of defeat. Some dream of a company in Buffalo, for just no reason. I dream of keeping capt. 370 in tight check, plunk down the money when a mathematical case can be made such as the rare winners have done in Vegas
I never thought about that, but that alters the risk/reward in a bad way.
In the case of aemd though after its 50 to 1 reverse split, in many cases one could buy but not sell. That caused the price to go up, so the lucky folks who got access first got to profit. By the time I got access, I could not sell at the high after the reverse split
I don't know about when. If Simpson did not have a lock with the offering holders, it makes no sense to hold a losing vote. Possibly she thinks the offering holders are a lock, but does not know.
If NO vote, it will be a nagging question over a step 2.
She may though have done all this to reinforce authorized vote. I think she could do whatever she wanted with 500 million more shares. Offering, seems very likely
Let's see about that vote. If the vote is YES on reverse split, Simpson has been approved by the offering holders, aka the silent bunch
I sold with a 25 percent loss. Everybody else could have sold, except if the price crashed too much, then the point of selling becomes confused.
The stock has been showing a lot of stability but vote has not been revealed.
Simpson is doing the right thing. It is right to reverse split. It is right to find new buyers. If she wins important victories including increased enrollment speed, 2019 can be the new 2010, there may be many capt. 370s
I think desert would be in favor of a bankruptcy where shareholders get zero versus reverse split. Maybe quite a few think that.
Anything is possible. If there is a run up and people make money and leave others behind at zero some will be happy.
Simpson was quite ethical to give update in detail on phase 3, but if anything just spurs people to think the worst